Royal Bank of Canada’s Zealand Pharma A/S American Depositary Shares ZEAL Stock Holding History

Royal Bank of Canada’s Portfolio ZEAL Stock Details ZEAL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-63	Closed	-$1K	–	8200
2022 Q2	$1K	Hold	63	–	–	﹤0.01%	7293
2022 Q1	$1K	Hold	63	–	–	﹤0.01%	7674
2021 Q4	$1K	Hold	63	–	–	﹤0.01%	7595
2021 Q3	$2K	Hold	63	–	–	﹤0.01%	7410
2021 Q2	$2K	Buy	+63	New	+$1.97K	﹤0.01%	7283

Other funds holding ZEAL

TimeScale Financial Danvers, Massachusetts $463M AUM 12.48% 1-Year Est. Return

Royal Bank of Canada's ZEAL Position: Q3 2022 in Review

Royal Bank of Canada sold out of Zealand Pharma A/S American Depositary Shares (ZEAL) in Q3 2022, closing a stake of 63 shares — an estimated $1K sold.

Royal Bank of Canada first reported a position in ZEAL in Q2 2021 and held it in 5 quarters. The position peaked at $2K in Q3 2021. 1 fund tracked by Wall St. Rank holds ZEAL as of Q3 2022.

Royal Bank of Canada reported no remaining Zealand Pharma A/S American Depositary Shares position as of Q3 2022 after selling out during the quarter.
Royal Bank of Canada sold 63 Zealand Pharma A/S American Depositary Shares shares in Q3 2022, an estimated $1K.
Royal Bank of Canada first reported a position in Zealand Pharma A/S American Depositary Shares in Q2 2021 and held it in 5 quarters.
Royal Bank of Canada's Zealand Pharma A/S American Depositary Shares position peaked at $2K in Q3 2021.
1 fund tracked by Wall St. Rank held Zealand Pharma A/S American Depositary Shares as of Q3 2022.

Based on Royal Bank of Canada's 13F filing for Q3 2022, filed 14 Nov 2022.